Literature DB >> 11889253

Intrathecal IgM synthesis in neurologic diseases: relationship with disability in MS.

L M Villar1, J Masjuan, P González-Porqué, J Plaza, M C Sádaba, E Roldán, A Bootello, J C Alvarez-Cermeño.   

Abstract

The authors studied the intrathecal IgM synthesis (ITMS) in paired sera and CSF samples from 65 patients with MS, 28 with CNS infection, 40 with other neurologic diseases and eight control subjects. ITMS was found in 30 patients with MS and in 20 with CNS infection, but not in patients with other neurologic diseases or in control subjects. In infectious samples, the ITMS is likely a primary response. In MS group, it was associated with higher Expanded Disability Status Scale index (p = 0.017).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11889253     DOI: 10.1212/wnl.58.5.824

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  21 in total

Review 1.  Humoral immunity in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.

Authors:  Anne H Cross; Jennifer L Stark
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

2.  Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis.

Authors:  P Perini; F Ranzato; M Calabrese; L Battistin; P Gallo
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03-30       Impact factor: 10.154

Review 3.  The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment.

Authors:  Andrew P Robinson; Christopher T Harp; Avertano Noronha; Stephen D Miller
Journal:  Handb Clin Neurol       Date:  2014

4.  Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor?

Authors:  Jessica Frau; Luisa Maria Villar; Claudia Sardu; Maria Antonietta Secci; Lucia Schirru; Diana Ferraro; Giancarlo Coghe; Lorena Lorefice; Giuseppe Fenu; Roberta Bedin; Patrizia Sola; Maria Giovanna Marrosu; Eleonora Cocco
Journal:  J Neurol       Date:  2017-12-22       Impact factor: 4.849

5.  Primary progressive multiple sclerosis and generalized myasthenia gravis: an uncommon association.

Authors:  G Bigliardi; J Mandrioli; F Valzania; P Nichelli; N Casula; A M Simone; P Sola
Journal:  Neurol Sci       Date:  2010-06-29       Impact factor: 3.307

Review 6.  The Multiple Roles of B Cells in Multiple Sclerosis and Their Implications in Multiple Sclerosis Therapies.

Authors:  Rui Li; Amit Bar-Or
Journal:  Cold Spring Harb Perspect Med       Date:  2019-04-01       Impact factor: 6.915

7.  Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients.

Authors:  Anne H Cross; Jennifer L Stark; Joanne Lauber; Michael J Ramsbottom; Jeri-Anne Lyons
Journal:  J Neuroimmunol       Date:  2006-08-14       Impact factor: 3.478

Review 8.  The potential role of B cell-targeted therapies in multiple sclerosis.

Authors:  Aaron Boster; Daniel P Ankeny; Michael K Racke
Journal:  Drugs       Date:  2010-12-24       Impact factor: 9.546

9.  Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS.

Authors:  Luisa M Villar; María C Sádaba; Ernesto Roldán; Jaime Masjuan; Pedro González-Porqué; Noelia Villarrubia; Mercedes Espiño; José A García-Trujillo; Alfredo Bootello; José C Alvarez-Cermeño
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

10.  A multifactorial prognostic index in multiple sclerosis. Cerebrospinal fluid IgM oligoclonal bands and clinical features to predict the evolution of the disease.

Authors:  Jessica Mandrioli; Patrizia Sola; Roberta Bedin; Mariaelena Gambini; Elisa Merelli
Journal:  J Neurol       Date:  2008-06-13       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.